Meet ClinSearch at these upcoming events
November
XVIII National Congress of the Cardiology Society of Serbia
November 24-27, 2011
Belgrade, SERBIA
TCT 2011
Transcatheter Cardiovascular Therapeutics
November 7-11, 2011
San Francisco, CA, USA
December
ICI Meeting 2011
Innovations in Cardiovascular Interventions
December 4-6, 2011
Tel-Aviv, Israel
In the meantime…
Please join us by phone or e-mail:
Sandy Maumus-Robert
ClinSearch
1 rue de l’Egalité | 92220 Bagneux, France
Phone:
+33 1 47 35 13 57 —
+33 6 61 65 71 10
sandy.maumus-robert@clinsearch.net
News
Morning Read: Non-profit designing free Wi-Fi architecture for hospitals >> Read
Managing retinal vein occlusion >> Read
Let Me Die on the Prairie by Frances Jane Crosby Van Alstyne >> Read
Publication: Volume 16, number 4 (Stevenson). Study found that no conclusive results can be provided on the cost-effectiveness of four non-invasive tests for liver fibrosis [the Enhanced Liver Fibrosis Test, FibroTest and FibroMAX and transient elastography (FibroScan)] in patients suspected of having alcohol-related liver disease. >> Read
Top headlines from HIMSS2012 (Tuesday edition) >> Read
Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis >> Read
Publication: Volume 16, number 3 (Hockenhull). Report finds that whilst some interventions targeted at mental health populations to reduce violence are well supported by the evidence a scattergun approach in the research literature provides little firm evidence for the majority of interventions. Evidence shows small-to-moderate effects for cognitive behavioural therapy for psychological interventions, and larger effects for atypical antipsychotic drugs. >> Read
How the NHS measures up to other health systems >> Read
Publication: Volume 16, number 5 (Ara). Although orlistat, sibutramine and rimonabant are all effective at reducing weight and body mass index and, compared with placebo, are all cost-effective, both sibutramine and rimonabant have been withdrawn because of safety concerns relating to potential treatment-induced fatal adverse events. >> Read
Peter John Fenton >> Read
Publication: Volume 16, number 6 (Reeves). The verteporfin photodynamic therapy cohort study found that treatment and follow-up were much less frequent in routine clinical practice than in research trials and the cost-effectiveness was similar to the highest previous estimate. >> Read
Frederick Valentine Flynn >> Read